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Hox genes encode homeodomain-containing proteins that control embryonic development in multiple contexts. Up to
30 Hox genes, distributed among all four clusters, are expressed during mammalian kidney morphogenesis, but
functional redundancy between them has made a detailed functional account difficult to achieve. We have
investigated the role of the HoxD cluster through comparative molecular embryological analysis of a set of mouse
strains carrying targeted genomic rearrangements such as deletions, duplications, and inversions. This analysis
allowed us to uncover and genetically dissect the complex role of the HoxD cluster. Regulation of metanephric
mesenchyme-ureteric bud interactions and maintenance of structural integrity of tubular epithelia are differentially
controlled by some Hoxd genes during renal development, consistent with their specific expression profiles. We also
provide evidence for a kidney-specific form of colinearity that underlies the differential expression of two distinct sets
of genes located on both sides and overlapping at the Hoxd9 locus. These insights further our knowledge of the
genetic control of kidney morphogenesis and may contribute to understanding certain congenital kidney
malformations, including polycystic kidney disease and renal hypoplasia.
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Introduction
Mammalian genomes contain 39 genes related to the
Drosophila homeotic genes, which encode transcription
factors necessary for proper development along the major
body axis. In the mouse, these Hox genes are organized in four
separate chromosomal clusters and are expressed along the
body axis in a spatio-temporal manner that corresponds to
their physical positions along the clusters [1,2]. Because these
four clusters were generated by large-scale duplications, Hox
genes are classiﬁed into thirteen groups of paralogy, based on
both sequence similarities and respective positions along the
clusters. These genes have long been recognized as important
regulators of developmental processes, in particular due to
their function in specifying regional identities along the
anterior to posterior body axis [3].
In the course of tetrapod evolution, Hox gene functions
were co-opted in a number of developmental processes
including the patterning of the limb bud and the formation
of several organ systems, where they positively or negatively
regulate the expression of genes involved in cell differ-
entiation, adhesion, proliferation and apoptosis [4]. The
intricate overlapping expression patterns and structural
homology of these gene products underlie many instances
of pleiotropy and functional redundancy, phenomena that
have substantially complicated their functional analysis.
Further untangling of this complex genetic system is
expected to yield novel insight into important developmental
mechanisms. For example, in the developing mammalian
urogenital system, simultaneous expression of about thirty
Hox genes has been reported, and some traces of colinear
regulation became apparent [5–7].
The early molecular events underlying kidney morpho-
genesis are functionally well described, and are initiated by
reciprocal epithelial-mesenchymal signaling interactions be-
tween the epithelium of the ureteric bud (UB) and the
metanephric mesenchyme (MM) [8]. In mouse, the UB forms
during embryonic day 10 (E10) as an epithelial protrusion in
the more posterior part of the Wolfﬁan duct. The nearby
mesenchyme (future MM) condenses and signals to induce
branching morphogenesis of the UB, whereas signals emanat-
ing from the UB in turn promote MM survival and activate
nephrogenesis. The induced MM expands, becomes a
polarized epithelium through the intriguing process of
mesenchyme to epithelium transition and forms vesicles that
elongate and differentiate to form the nephrons. Molecular
genetic analyses in mice have revealed a complex network of
regulatory interactions that control kidney organogenesis,
involving transcription factors, cell adhesion proteins and
secreted molecules [8].
In this context, few studies have addressed the function of
Hox genes during kidney morphogenesis, except for paralogy
group 11; while single mutations in any of the Hox11 group
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gene results in normal nephrogenesis, double or triple
mutations lead to either absent, or rudimentary kidneys,
with a severely reduced number of nephrons [9,10]. Gain of
function approaches have suggested a richer variety of HOX
function in kidneys, since the over-expression of Hoxb8 and
Hoxb7 caused kidney hypoplasia and renal duplication,
respectively [11,12], whereas the ectopic expression of Hoxd13
induced renal agenesis [13].
In order to assess the total functional contribution of Hoxd
genes to kidney development, we performed detailed com-
parative phenotypic analysis of a set of mouse strains carrying
a variety of targeted genomic rearrangements within the
HoxD cluster. We show that the most striking kidney defect at
birth is a failure of UB branching morphogenesis, leading to
kidney hypoplasia associated with early postnatal death. This
defect correlates with a gain of expression of the posterior
Hoxd12 gene in developing kidneys. Interestingly however,
defects reminiscent of polycystic kidney disease (PKD) were
also observed, yet exclusively in mutant mice carrying a
deletion of more anterior Hoxd genes like Hoxd9 and Hoxd8.
Finally, the distinct functions of Hoxd genes in kidneys
correlate well with their speciﬁc expression in the MM or
UB, respectively. In this context, we use some additional
mutant strains to provide evidence for the presence of
putative global enhancer and silencer elements, which deﬁne
and coordinate the expression pattern of Hoxd genes in
developing kidneys.
Results
Multiple Kidney Defects in HoxD Cluster Deficiency
As several Hoxd genes are expressed during kidney
development, multiple modes of functional redundancy or
compensatory mechanisms may remain easily hidden in
single gene inactivation experiments [7,10]. We thus ad-
dressed this question by using more drastic genetic con-
ditions and ﬁrst compared renal development in a variety of
mouse strains carrying targeted deletions of multiple Hoxd
genes in cis (Figure 1A). The shortest of these deletions
removed the DNA interval including from Hoxd10 to Hoxd11,
and is referred to as Del(10–11), whereas the largest deletion
Del(1–13) removed the entire HoxD cluster, from Hoxd1 to
Hoxd13 included (Figure 1A). Other deletions Del(10–13),
Del(4–13) and Del(4–11) removed the corresponding inter-
mediate sets of Hoxd genes. Importantly, while both Del(10–
11) and Del(10–13) deletions removed Hoxd genes expressed
in the MM only, other deﬁciencies involved heterogenous sets
expressed either in the epithelium, or in the mesenchyme [7].
While homozygous pups derived from all mutant strains
were obtained at birth following a Mendelian proportion, all
homozygous Del(4–11) newborns (100%) and between 40 to
50% of the Del(4–13) and Del(1–13) homozygous pups died
shortly after birth. When compared to wild-type (WT)
littermates at birth, Del(10–13), Del(4–13) or Del(1–13)
homozygous mutants displayed grossly normal kidneys,
whereas Del(10–11) and Del(4–11) animals showed slight or
strong reduction in the size of their kidneys, respectively
(Figure 1B). As expected from such severe kidney hypoplasia,
histological analysis of Del(4–11) homozygous kidneys re-
vealed a strong reduction of UB branching reﬂected in a
reduced number of collecting tubules in the medulla region,
when compared to control and other mutant strains (Figure
2A, top). In addition, UB branching was slightly decreased in
Del(10–11) kidneys. Because the severe hypoplasia found in
Del(4–11) kidneys was absent from both Del(4–13) and Del(1–
13) homozygous mice, we concluded that a mis-regulation of
the remaining Hoxd12 and/or Hoxd13 genes was likely the
cause of this postnatal lethality.
The abnormal reduction in the number of UB branches in
Del(10–11) and Del(4–11) newborn kidneys was further
documented by using immuno-histochemical detection of
CADHERIN type 1 (CDH1), a marker speciﬁc for developing
UB and epithelial tubules (Figure 2A, bottom). As appropriate
branching of the UB is essential to set the number of
nephrons, we next determined the volume and glomerular
density of WT and mutant kidneys by quantitative morph-
ometry. In both Del(10–11) and Del(4–11) mice, cortical and
medullar volumes were reduced when compared to other
strains (Figure 2B, left). Furthermore, the density of glomeruli
was signiﬁcantly reduced in Del(4–11) kidneys (Figure 2B,
right), further conﬁrming a role for Hoxd genes in the control
of UB growth.
Histological examination also revealed the presence of
tubular dilatations in both the medulla and the cortex of
Del(4–11), Del(4–13) and Del(1–13) homozygous newborn
kidneys (Figure 2A, top). These defects were observed in
heterozygous mutants too, although clearly less frequently.
Higher magniﬁcations revealed microcystic changes in these
tubules, characterized by abnormally thin epithelial cells and
widened lumina, resembling renal cysts observed in PKD
(Figure 3, top). Most cysts originated from the UB lineage, as
shown by staining with the collecting-duct speciﬁc lectin
Dolichos biﬂuoris agglutinin (DBA; Figure 3, middle). In
addition, CDH1 immuno-staining, an indicator of cystic
kidneys in mice [14], was lost in the plasma membrane of
cystic tubules from both Del(4–11) and Del(4–13) homozygous
kidneys, suggesting a defect in epithelial cell polarity (Figure
3, bottom). Finally, escaper Del(1–13) homozygous mice,
surviving birth for at least one month, developed different
degrees of well-visible unilateral or bilateral polycystic
kidneys (Figure S1).
Altogether, the abnormal kidney architecture observed in
the different HoxD deletions suggested important roles for
these genes during renal morphogenesis. On the one hand,
the hypoplastic phenotype found in both Del(10–11) and
Del(4–11) mice involved a mis-regulation of the remaining
posterior Hoxd12 and Hoxd13 genes, reminiscent of gains of
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Author Summary
Hox genes encode proteins that control embryonic development
along the head-to-tail axis and in multiple organs. Here, we show
that several members of this gene family are necessary for the
normal development of the mammalian kidneys. These genes are
clustered in one site on the chromosome and their respective
positions within the group determine which component of the
kidneys they will contribute to. Using a large collection of
engineered mutations in this system, we show that these genes
are required both for the growth of the kidneys and for their proper
organization, such that mutations in some genes reduce the size of
the organs, whereas mutations in others induce polycystic kidneys.
Our set of genetic rearrangements also allowed us to localize the
position of regulatory sequences, which control the expression of
these genes during kidney development.
expression as previously seen during the development of the
limbs [15]. On the other hand, the microcystic defects were
likely induced by the loss of either Hoxd4, Hoxd8 or Hoxd9, or
combinations thereof, as suggested by their occurrence in
Del(1–13), Del(4–13) and Del(4–11), but not in Del(10–11) or
Del(10–13) homozygous animals.
Aberrant Cell Death in HoxD Mutant Polycystic Kidneys
Kidney morphogenesis depends upon a delicate balance
between cell proliferation and apoptosis. We thus assessed
whether the growth defects observed in our HoxD deleted
mice could derive from modiﬁcations in the rates of either
one of these processes. Immuno-detection of phosphorylated
histone H3 (P-H3), a nuclear protein present in mitotic cells
only, showed distribution of proliferating cells in the differ-
ent compartments of developing kidneys at birth, with
relatively higher levels in the cortex (Figure 4A, top).
Quantitative analysis of P-H3-positive cells revealed no
signiﬁcant difference between WT kidneys and age-matched
Del(10–11), Del(10–13), Del(4–11) or Del(4–13) mutants
(Figure 4A, bottom left).
In control newborn kidneys, TUNEL-positive, apoptotic
cells were barely detected, either in the nephrogenic zone, or
in the medullary papilla (Figure 4A, top). In contrast,
apoptosis was increased ﬁve to six fold in both Del(4–11)
and Del(4–13) kidneys (Figure 4A, bottom right). In these
cases, apoptotic cells were particularly numerous in the
cortical interstitium as well as in the microcystic tubules
previously identiﬁed in these two HoxD deletions (Figure 4B).
No signiﬁcant changes were observed either in Del(10–11), or
in Del(10–13) mutants (Figure 4A), suggesting a critical
involvement of the Hoxd4-Hoxd9 genomic interval. Therefore,
the precise balance between proliferation and apoptosis was
clearly disturbed in both Del(4–11) and Del(4–13) cystic
kidneys, with a robust increase in tubular epithelial cell
apoptosis, similar to what happens in human and animal
models of PKD [16].
Effects of the Deletions upon Neighboring Hoxd Genes
To explore the molecular mechanisms underlying the UB
branching defects, we analyzed the expression pattern of
those Hoxd genes ﬂanking the internal Del(10–11) and Del(4–
11) deletions, using both quantitative RT-PCR (qPCR) and in
situ hybridization (ISH), to detect potential deletion-induced
mis-regulations [15]. By using qPCR and kidneys from
embryonic day E13.5 fetuses to postnatal day 0 (P0), we
observed a strong gain of expression of Hoxd12 in Del(4–11)
kidneys, and a reproducible increase was also noticed in
Del(10–11) mice (Figure 5A). Del(10–13) and Del(4–13)
kidneys were used as negative controls for the speciﬁcity of
Hoxd12 gene ampliﬁcation. No (or only very slight) difference
was observed in the expression levels of Hoxd3 under the same
circumstances (Figure 5A).
We next analyzed the distribution of Hoxd12 mRNA by ISH
in WT, Del(10–11) and Del(4–11) kidneys at E15.5 and P0,
using Del(4–13) as a negative control (Figure 5B). In WT
kidneys, Hoxd12 was expressed rather diffusely within the MM
at E13.5, whereas it was detected mainly in the central MM
Figure 1. Effects of HoxD Cluster Deletions upon Renal Morphology
(A) Scheme showing the intact HoxD gene cluster (top line) and five strains of mice carrying deletions at the locus which were used to assess the
functions of various Hoxd genes in kidney development. The intergenic region between Hoxd4 and Hoxd8 is referred to as ‘region i’. The neighboring
gene Evx2 is shown as a grey box. Brackets indicate the deletion breakpoints and the deleted fragments are shown in dashed lined. For convenience,
the strains are referred to as, e.g., Del(10–11) for a deletion removing from Hoxd10 to Hoxd11, inclusively. Strains are ordered according to the increasing
size of the deleted fragment in the HoxD cluster.
(B) Gross appearance of representative kidneys from control wild type (WT) and HoxD mutant newborn mice. The Del(10–11) and Del(4–11) strains
exhibit kidney hypoplasia, whereas adrenal glands appeared normal.
doi:10.1371/journal.pgen.0030232.g001
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surrounding the main trunk of the UB at birth, with lower
expression in MM cells at the periphery of the kidney. In
addition to the expression in the MM, Del(10–11) kidneys also
showed Hoxd12 mRNA in some UB branches as well as UB
tips, at the junction with the distal segments of the S-shaped
body (Figure 5B, bottom). Finally, Hoxd12 was strongly mis-
expressed in the UB branches and tips of Del(4–11) kidneys at
both E13.5 and P0. Hoxd13 expression was undetectable at all
these developmental stages, both in the various mutants as
well as in WT controls ([7] and data not shown).
These results demonstrated that, as a result of the
intervening deletions, the Hoxd12 transcription unit became
progressively mis-expressed and shifted its expression from
MM to UB, presumably due to its closer proximity to the
more anterior (3’) part of the cluster. Importantly, these
changes in the quantitative level and tissue distribution of
Hoxd12 expression correlated well with the UB branching
defects observed in both Del(10–11) and Del(4–11) mutant
kidneys.
Hoxd Regulation of Epithelial-Specific Genes in
Developing Kidneys
We investigated the expression of various genes known as
regulators of kidney development, in order to identify
Figure 2. Histology of Neonatal HoxD Mutant Kidneys
(A) Sagittal sections of newborn kidneys (strains are indicated on the top) were stained with hematoxylin and eosin (H&E, top). At high magnifications,
tubular dilatations and large cysts were visible in both the cortical and medullary region of Del(4–11), Del(4–13) and Del(1–13) strains. In the bottom
panels, newborn kidneys were processed for the detection of CDH1 in order to identify the UB and its branches.
(B) The volume (left) and glomerular density (right) of HoxD mutant newborn kidneys were compared with WT control littermates. The volume was
separated into distinct cortical (cortex) and medullary (medulla) zones and was expressed as a ratio to body weight (mm3/g). The glomerular density
represents the number of glomeruli per total volume of kidney (n8/cm3). Independent Student’s t test (HoxD deletions versus WT): *, P , 0.05; **, P ,
0.01.
doi:10.1371/journal.pgen.0030232.g002
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potential genetic targets of Hoxd gene products. We started
with the hypoplasia phenotype, common to both Del(10–11)
and Del(4–11) mutant mice. The hypoplasia observed in
Del(4–11) mice was similar to the effect of Hoxa11/Hoxd11
double loss of function [9], suggesting that the up-regulation
of Hoxd12 expression, in this allele (Figure 5), negatively
affects the function of group 11 proteins. A similar
mechanism has been proposed for explaining complete
kidney agenesis or severe hypoplasia in the TgH[d9/lac]
transgenic conﬁguration, wherein the insertion of a trans-
gene near Hoxd13 up-regulated this latter gene in developing
metanephric kidneys [13].
To investigate this hypothesis, we analyzed by qPCR the
expression of several genes reported to be strongly mis-
regulated in Hoxa11/Hoxd11 double mutant kidneys [17].
However, both Del(4–11) and Del(4–13) homozygous kidneys
exhibited normal expression of all genes assayed in this
respect (Figure S2). In contrast, similar analyses carried out
on the TgH[d9/lac] transgenic mice revealed a signiﬁcant
increase of both Gata6 and Tgfb2 expression, two genes
described as target of Hoxa11/Hoxd11 [17], together with a
massive gain of expression of Hoxd13 in the MM and
subsequent kidney hypoplasia (Figure S3).
Because the gain of Hoxd13 expression in the MM of
TgH[d9/lac] transgenic kidneys involved modiﬁcations in
MM-speciﬁc genes (Gata6 and Tgfb2), we investigated whether
the gain of posterior Hoxd gene expression in the UB of
Del(4–11) mice could affect the expression of UB-speciﬁc
genes, instead of the previously tested MM candidates. Little
(if any) difference was scored amongst the various HoxD
strains, upon analyses of the expression levels of a battery of
genes known to regulate UB branching (Figure 6A and S4A).
Interestingly however, a severe reduction of embryonic and
postnatal integrin-a3 (Itga3) gene expression was observed in
Del(4–11) hypoplastic kidneys, as compared to their WT and
Del(4–13) counterparts (Figure 6A). A slight down-regulation
of Itga3 was already present in the Del(10–11) kidney, whereas
a normal expression level was found in the TgH[d9/lac]
transgenic strain (data not shown).
The Itga3 gene was of particular interest in this context,
since its functional inactivation leads to mice with similar
defects in branching morphogenesis and microcystic pheno-
types than those observed in our Del(4–11) mutants [18].
Altered expression of Itga3 in Del(4–11) kidneys was further
conﬁrmed at the protein level by using immuno-ﬂuorescence.
ITGa3 is present in both the UB and glomerular podocytes,
along the glomerular basement membrane (GBM) of WT
kidneys (Figure 6B and reference [19]). Strikingly, ITGa3
Figure 3. Development of Cystic Kidneys
H&E stained-sections illustrate microcystic changes in a subset of tubules in Del(4–11) and Del(4–13) kidneys (top). Cryosections of WT, Del(4–11) and
Del(4–13) newborn kidneys were either stained with Dolichos biflorus agglutinin (DBA, middle panels), a specific marker of epithelial tubules, or
processed for the detection of CDH1 by immuno-fluorescence (CDH1, bottom panels). Cell nuclei were counterstained with DAPI (DAPI, blue). Renal
tubules are shown at higher magnification in the insets.
doi:10.1371/journal.pgen.0030232.g003
PLoS Genetics | www.plosgenetics.org December 2007 | Volume 3 | Issue 12 | e2322504
Hoxd Genes in Kidney Development
immuno-staining was virtually lost in Del(4–11) mutant UB
branches and tips, when compared to WT and Del(4–13)
controls (Figure 6B, top and middle). In addition, the GBM
was disorganized in a number of Del(4–11) mutant kidneys, as
shown by reduced capillary branching (Figure 6B, bottom).
These glomerular anomalies are consistent with an essential
role of ITGa3 in the maturation of the GBM [20], and may
result in the loss of normal glomerular ﬁltration barrier in
Del(4–11) kidneys.
Hoxd Control of Apoptosis in Renal Tubules
We then focused on the polycystic kidney phenotype,
common to both Del(4–11) and Del(4–13) mutant mice.
Because these cystic kidneys displayed increased apoptotic
activity (Figure 4), we used qPCR to determine the expression
levels of those apoptotic genes known to trigger a cystogenic
pathway in mouse dysplastic kidneys (Figure 7A and S4B) [21].
The RNA content of c-myc and p53, two important pro-
apoptotic gene markers of PKD [16], were both increased in
Del(4–11) and Del(4–13) kidneys, when compared to WT
controls (Figure 7A). Expectedly, C-MYC was detected in a
nuclear pattern in epithelial cystic tubules of both Del(4–11)
and Del(4–13) kidneys (Figure 7B). In addition, we scored a
strong up-regulation of growth and differentiation factor-5 (Gdf5)
in these two mutant kidneys, coincident with the observed
cystic dilatations of epithelial tubules. Gdf5 mRNA and
Figure 4. Cell Death in Del(4–11) and Del(4–13) Mutant Kidneys
(A) Sections of WT, Del(10–11), Del(10–13), Del(4–11) and Del(4–13) newborn kidneys, double stained for phosphorylated histone H3 (P-H3 mitotic
marker, green) and TUNEL (apoptotic marker, red). Cell nuclei were counterstained with DAPI (DAPI, blue). Graphs show the percentage of P-H3- (left)
and TUNEL-positive cells (right) among the total population of renal cells. Independent Student’s t test: **, P , 0.01.
(B) Double staining for DBA (green) and TUNEL (red) was performed in order to identify the renal origin of apoptotic cells in the Del(4–11) and the
Del(4–13) strains. Apoptotic cells are scored in epithelial microcysts (arrowheads) and in the renal interstitium of mutant kidneys.
doi:10.1371/journal.pgen.0030232.g004
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protein expression levels were elevated in Del(4–11) and
Del(4–13) kidneys, in both non-cystic and cystic tubules, as
revealed by ISH and immuno-ﬂuorescence, respectively
(Figure 7B, top).
Members of the TGFb super-family trigger cellular re-
sponses through the SMAD protein pathway, which trans-
duces the signal from the cell surface to the nucleus to
activate speciﬁc gene transcription [22]. We thus analyzed the
expression of phosphorylated SMAD 1-5-8 proteins (P-
SMADs) in cystic kidneys, as a cellular reporter of TGFb
pathway activation. Although P-SMADs were expressed at low
levels, in a cytoplasmic pattern in epithelial tubules from
control tissue, they were robustly up-regulated in both the
cytoplasms and nuclei of microcystic tubules from Del(4–11)
and Del(4–13) kidneys (Figure 7B), suggesting an increased
activity of the BMP/GDF pathways in these tubules.
Hoxd8 and Hoxd9 Regulate Epithelial Microcyst Formation
The polycystic kidney phenotype was observed only in
those HoxD cluster deletions which remove both anterior and
posterior Hoxd genes, such as Del(4–11), Del(4–13) and Del(1–
13). In contrast, this phenotype never developed in those
strains where only posterior genes had been affected, such as
Del(10–11) and Del(10–13), suggesting that this alteration was
caused by (a) gene(s) lying within the Hoxd9 to Hoxd4 interval
(Figure 2).
To further clarify the importance of these genes in the
formation of microcysts, we used two novel mutant strains,
carrying either a deletion or a duplication of the region
located between Hoxd9 and the intergenic ‘region i’ (Del(i-9)
and Dup(i-9); Figure 8A), i.e. deleting or duplicating in cis
both Hoxd9 and Hoxd8. Histological examination of Del(i-9)
homozygous kidneys revealed the presence of epithelial
microcysts, as well as an increased tubular Gdf5 expression
(Figure 8B). In this allele, the expression of neighboring
posterior and anterior Hoxd genes was not importantly
modiﬁed, strongly arguing against any potential global
regulatory re-allocations that may have triggered a cystic
phenotype (Figure S5 and data not shown). As mentioned
earlier, microcystic tubules were also observed in Del(1–13)
heterozygous kidneys, with a penetrance of about 50 percent
(3 out of 6 mice), consistent with the loss of function
explanation involving Hoxd8 and Hoxd9. Interestingly, these
Figure 5. Expression of Hoxd Genes Flanking the Deletions
(A) qPCR analysis was carried out at embryonic or postnatal days (from E13.5 to P0), using cDNAs generated from control (WT) and HoxD mutant kidney
mRNAs. Values represent the mean of three independent experiments, after normalization to the WT at day E13.5. Independent Student’s t test (HoxD
deletions versus WT): *, P , 0.05; **, P , 0.01.
(B) The detection of Hoxd12 was performed in WT, Del(10–11), Del(4–11) and Del(4–13) kidneys at E.13.5 and P0, by ISH. The Del(4–13) allele was used as
a negative control for the specificity of the riboprobe. Del(10–11) and Del(4–11) kidneys showed Hoxd12 mRNA in some UB branches (red arrowheads)
as well as UB tips (black arrowheads and insets).
doi:10.1371/journal.pgen.0030232.g005
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renal defects were never observed in six compound mutant
mice generated on the same genetic background, which were
trans-heterozygous for Del(1–13) and Dup(i-9), suggesting a
rescue from the duplicated allele (Figure 8C, top). In these
Del(1–13)/Dup(i-9) animals, the two copies of Hoxd9 and
Hoxd8, coming from the duplicated DNA segment were likely
expressed at similar levels, since expression was about two-
fold higher than in Del(1–13) heterozygous kidneys (Figure
8D). However, while Hoxd9 expression level was similar in the
MM, it was clearly higher in the UB, suggesting that the
second Hoxd9 gene copy was mostly expressed in the UB
(Figure 8C, bottom). By using whole mount in situ hybrid-
ization, Hoxd8 was detected only in the UB of WT and Del(1–
13) kidneys, with relatively higher expression in Del(1–13)/
Dup(i-9) kidneys (data not shown). Accordingly, the expres-
sion of Gdf5 and c-myc also decreased in Del(1–13)/Dup(i-9)
kidneys, reaching levels observed in WT conditions (Figure
8D). These results suggest a role for Hoxd9 and Hoxd8 (and
perhaps for ‘region i’) in the regulation of tubular epithelia in
postnatal kidneys.
Figure 6. Expression of Adhesion Molecules in HoxD Mutants
(A) Expression of Itga3 and Cdh1 was assessed by qPCR from E13.5 to P0. Independent Student’s t test (HoxD deletions versus WT): *, P , 0.05; **, P ,
0.01.
(B) In newborn kidneys, the ITGa3 protein was abundant in the UB and in glomeruli, as revealed by immuno-fluorescence (green). However, ITGa3
immuno-staining was largely reduced in UB tips (top) and branches (middle) of Del(4–11) mutant when compared to WT and Del(4–13) kidneys. In
addition, the basement membrane structure of Del(4–11) mutant glomeruli was disorganized (bottom). Cell nuclei were counterstained with DAPI
(blue).
doi:10.1371/journal.pgen.0030232.g006
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Looking for Mesenchymal and Ureteric Bud Enhancers
In order to determine the inﬂuence of Hoxd genes’
clustered organization on their transcriptional regulation in
MM and UB kidney cell types, we used a collection of mouse
strains containing the same reporter transgene together with
progressively more extended deletions of the HoxD cluster
(Figure 9A, top). In these strains of mice, a Hoxd11/lacZ fusion
gene effectively replaced the deleted regions and thus allowed
for histochemical detection of b-galactosidase activity in
kidneys. In this way, the transcriptional behavior of the same
reporter gene could be assessed when located at various
positions within the gene cluster. As expected from the
absence of Hoxd13 expression in kidneys, reporter activity was
not detected when the fusion gene was positioned at the
posterior end of the HoxD complex ﬂanked by Hoxd13 on its 3’
side (TgH[d11/lac]; Figure 9A, bottom). However, the prox-
imity of progressively more 3’ parts of the HoxD cluster
induced accompanying progressively more anterior shifts of
reporter gene expression along the trunk (data not shown),
including a shift from MM to UB. While Del(12–13) and
Del(11–13) strains showed strong b-galactosidase activity in
the MM, only UB but no MM cells were stained when the
deletions brought the transgene closer to the 3’ (telomeric)
part of the cluster (Figure 9A, bottom). These expression
patterns were suggestive of the existence of two distinct
enhancer sequences, one controlling expression of ‘posterior’
Figure 7. Expression of Apoptotic-Related Genes in HoxD Mutant Kidneys
(A) qPCR measurements of the indicated genes were performed in newborn kidneys from WT, Del(10–11), Del(10–13), Del(4–11) and Del(4–13) strains.
Values represent the mean of three independent experiments, after normalization to the WT. Independent Student’s t test (HoxD deletions versus WT):
*, P , 0.05; **, P , 0.01.
(B) An increased expression of Gdf5 in the epithelial tubules of Del(4–11) and Del(4–13) newborn kidneys was observed both at the mRNA and protein
levels (top). C-MYC and phospho-SMADs (bottom) were also up-regulated in renal tubules. Tubules are shown at higher magnification in the insets. Cell
nuclei were counterstained with DAPI (blue).
doi:10.1371/journal.pgen.0030232.g007
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genes in the MM, the other triggering expression of more
‘anterior’ Hoxd genes in the UB.
Because reporter transgene activity in the UB persisted
even when the HoxD cluster was entirely deleted, a putative
UB enhancer ought to localize outside the cluster itself. On
the other hand, reporter gene activity in the mesenchyme was
scored in the Del(11–13) strain, whereas absent in Del(i-13)
animals, suggesting that a mesenchyme enhancer activity may
reside within the cluster, between Hoxd10 and ‘region i’.
However, in mice lacking either halves of this region (i.e.
Del(i-9) or Del(10–11)), expression of the remaining posterior
Hoxd genes in the MM was still clearly detected (Figure 5B and
S5). From these observations, we conclude that the absence of
reporter activity in the MM of Del(i-13) mice is not due to the
deletion of the corresponding enhancer sequence. Conse-
quently, this putative regulatory sequence must lie either in
the most anterior part of the cluster (within the Hoxd4 to
Hoxd1 region) or, like for the UB regulation, outside the
cluster itself.
Because enhancers controlling Hoxd gene expression in
Figure 8. Deletion of Both Hoxd8 and Hoxd9 Leads to Epithelial Microcyst Formation
(A) Scheme showing the intact HoxD cluster (top) and two newly produced mouse strains used to characterize Hoxd genes responsible for microcyst
formation. The strains are referred to as Del(i-9) or Dup(i-9) for a deletion or a duplication, respectively, and they span from ‘region i’ to Hoxd9,
inclusively (dashed lined).
(B, C) Kidney cryosections of WT (þ/þ), Del(i-9) homozygous (Del(i-9)/Del(i-9), Del(1–13) heterozygous (Del(1–13)/þ) and Del(1–13)/Dup(i-9) compound
mice were either stained with H&E (top), or processed for the detection of Gdf5 (left) or Hoxd9 (right) by ISH. The Del(1–13)/Dup(i-9) compound strain
was obtained by breeding Del(1–13) and Dup(i-9) heterozygous mice.
(D) qPCR was used to compare the expression levels of Hoxd9, Hoxd8, Gdf5 and c-myc in newborn kidneys from the mouse strains described before.
Values represent the mean of three independent experiments, after normalization to the WT. Independent Student’s t test: **, P , 0.01.
doi:10.1371/journal.pgen.0030232.g008
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Figure 9. Searching for Putative Mesenchyme and Ureteric Bud Enhancers
(A) Schematic representation of a panel of in vivo HoxD alleles containing the Hoxd11/lacZ fusion reporter gene together with progressive deletions of
the cluster. Blue boxes (lacZ) indicate the position of the same reporter transgene at the posterior end (5’, left) of the intact (TgH[d11/lac]) or deleted
(Del) HoxD cluster. Representative stainings of newborn kidneys are shown below.
(B) Scheme of the inversion-mediated split of the HoxD cluster between Hoxd11 and Hoxd10 (top; Split(10–11)) [23], separating the two half-clusters by
approximately 3 Mb. ISH for Hoxd11 and Hoxd10 genes (left), as well as qPCR for Hoxd12, Hoxd11, Hoxd10 and Hoxd8 (right) were carried out in WT and
Split(10–11) specimen. Independent Student’s t test: **, P , 0.01.
(C) Model of global Hoxd gene regulation during kidney development. The different expression domains are likely controlled by regulatory elements
localized outside the HoxD complex, at the telomeric (3’) side. The bud enhancer may control the expression of anterior genes (from Hoxd9 to Hoxd1) in
the UB (red arrows). Posterior Hoxd genes are not responsive to this enhancer, because of the presence of a putative silencer or boundary element
(green arrow), located between Hoxd10 and Hoxd11. The mesenchyme enhancer may trigger the expression of posterior genes (from Hoxd12 to Hoxd9)
in the MM.
doi:10.1371/journal.pgen.0030232.g009
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limbs are functionally separated and distributed on either
sides of the cluster [23], we further tried to map these
putative ‘kidney enhancers’. To this aim, we used mice
carrying a large inversion that splits the HoxD cluster into
two parts, between Hoxd11 and Hoxd10 [23], separated by a 3
Mb large DNA fragment (Figure 9B, top). In such mice, the
HoxD cluster is split into two sub-clusters with independent
regulations [23]. In WT newborn kidneys, the expression of
both Hoxd11 and Hoxd10 was detected in the MM only (Figure
9B, left). Interestingly, after separating the complex, mutant
kidneys completely lost expression of both Hoxd11 and
Hoxd12, whereas expression of Hoxd10 in the MM remains
unchanged. Quantitative analyses by using qPCR conﬁrmed
the abrogation of Hoxd12 and Hoxd11 expression in this allele,
whereas Hoxd10 or other UB-speciﬁc genes, such as Hoxd8,
exhibited slightly higher than normal expression levels,
respectively (Figure 9B, right). Altogether, these results
strongly suggest that the putative global enhancer sequences
controlling the expression of Hoxd genes in both MM and UB
are located either within the most telomeric part of the HoxD
cluster, or further outside in 3’.
Discussion
In this paper, we report distinct roles for Hoxd genes during
kidney development. While the most posterior genes (from
Hoxd13 to Hoxd11) are involved in the regulation of
metanephric mesenchyme-ureteric bud interactions (this
study and [10]), genes located at more ‘anterior’ positions,
such as Hoxd9 and Hoxd8, are required to maintain the
integrity of the renal tubular epithelia. The gain of function
of Hoxd12 was indeed associated with defects in UB branching
and glomeruli formation, in parallel with a down-regulation
of the cell adhesion molecule ITGa3. On the other hand, the
absence of anterior gene functions, including that of Hoxd9
and Hoxd8, lead to the development of polycystic kidneys,
likely resulting from the activation of the BMP/GDF apoptotic
signaling pathway in epithelial tubules. Finally, this work
suggests a model whereby global regulatory sequences,
located on the same side of the cluster, deﬁne the allocation
of particular Hoxd genes either to mesenchymal cells, or to
epithelial parts of the developing kidney, due to their
respective genomic position within the gene cluster.
Posterior Hox Genes Are Important Regulators of Kidney
Morphogenesis
A high proportion of Hox genes are expressed in both
human and mouse kidneys [6,7] and several reports have
pointed to an important role for these genes during renal
development. Functional studies in mice have illustrated the
functional overlap that exists between paralogous genes as
well as between genes that are adjacent to each other in the
same cluster. While a single mutation in any gene of
paralogous group 11 results in normal nephrogenesis, double
or triple mutations lead to either absent, or rudimentary
kidneys, indicating a critical role for paralogous group genes
in UB branching morphogenesis [9,10]. Furthermore, the
combined inactivation of Hoxa10 and Hoxd10 altered both the
position and the size of developing kidneys [24], and some
renal size reductions were also scored in Hoxd9/Hoxd10 double
mutant mice [25].
Here, we show that TgH[d9/lac] and Del(4–11) mutant mice
have a reduced branching morphogenesis. In the former case,
we explain this by the strong gain of Hoxd13 expression in
developing kidney mesenchyme, which negatively affects the
function of group 11 paralogs, through a process known as
‘posterior prevalence’, whereby the product of posterior
genes can override the function of more anterior products
[26]. Ectopic Hoxd13 expression led to a failure of the mutant
MM to properly induce UB branching, similar to the
phenotype of combined group 11 loss of functions. In the
latter case, the gain of function involves Hoxd12 in the UB,
which leads to branching inhibition as well as podocyte GBM
defects, coherent with the down-regulation of the cell
adhesion molecule ITGa3.
Although experimental evidence supports a link between
posterior Hoxd genes and Itga3 in developing kidneys, the
demonstration of a direct interaction between these compo-
nents, so far hampered by the lack of fully speciﬁc anti-HOX
antibodies, remains to be established. Firstly, Itga3 deﬁcient
newborn mice exhibit UB branching and GBM defects similar
to those reported here, due to impaired epithelial cytoske-
leton organization [19]. Secondly, a3 subunit-containing
integrins bind with high afﬁnity to isoforms of laminin-10
and11, which are the predominant integrin ligands in both
the UB and mature glomeruli [19]. Interestingly, targeted
disruption of these laminins leads to hypoplastic kidneys [18].
Also, accumulating evidence suggests the existence of func-
tional links between these two groups of genes in a variety of
tissues and contexts [27]. In mouse kidney cell lines, for
instance, Itga8 and Iap are targets of Hoxa11 [28], whereas the
ITGa3 gene is regulated by HOXD3 and HOXD10 in some
human cancers [29,30]. Finally, Hox genes may regulate the
progression of human kidney diseases, including glomerulo-
nephritis, diabetic nephropathy and PKD, where integrins
have been reported to play an important role [19].
Hoxd Genes in Polycystic Kidney Disease
PKD, one of the most frequent human genetic disorders,
constitutes a major cause of end stage renal failure worldwide
[21]. In human and rodent models of PKD, pathological
features include increased apoptosis, as well as dedifferentia-
tion, adhesion and ciliary abnormalities of epithelial cells
[16]. Cystic kidneys were previously observed in a fraction of
Hoxd11 null mice containing a chimeric Hoxa11 allele with the
Hoxa4 homeobox [31]. In this work, we show that the
combined deletion of Hox gene functions (Hoxd9 and Hoxd8)
leads to the development of polycystic kidneys. The com-
parative analysis of renal development and gene expression
in the various HoxD deleted strains also revealed a signiﬁcant
increase of the cystic phenotype in Del(4–13) and Del(1–13)
mice, as compared to Del(4–11) and Del(i-9), suggesting some
participation of Hoxd12 in the regulation of the mesenchy-
mal-epithelial transition in developing tubules. In previous
studies, this loss of function phenotype may have been
compensated for by functional redundancy, as illustrated
either for the group 11 Hox genes [10], or between non
paralogous genes expressed in similar kidney compartments
[7].
Of note, mice lacking either all group 9 or all group 8 genes
die soon after birth for unknown reasons [32,33], which may
illustrate a protective role of Hoxd9 and Hoxd8 against the
development of PKD. Also, loss of these genes was reported to
have occurred in different human cancers affecting kidneys,
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the thyroid and breast tissues [34,35], even though a direct
causal relationship was not established. In addition, a detailed
analysis of the set of genes mis-regulated in a murine model
of PKD revealed no difference (or a slight decrease) for Hoxd9
and Hoxd8 expression, whereas the neighboring Hoxd10,
Hoxd4 and Hoxd3 were all increased [36]. These observations
support the hypothesis that Hoxd9 and Hoxd8 genes might be
necessary to maintain a given differentiated phenotype in
epithelial cells.
In mice, PKD can be induced by mutations in a variety of
genes, including several members of the BMP/GDF family of
proteins such as BMP4 and BMP7 [37]. Here, we report the
up-regulation of another member of the family, GDF5, in
Hoxd mutant polycystic kidneys. Like BMPs, GDF proteins
trigger cellular responses through their binding to type-I
receptors (preferentially ALK3 and ALK6) and subsequent
activation of the SMAD pathway (Smad 1-5-8), which relays
the signal from the cell surface to the nucleus to activate
speciﬁc gene transcription [22]. Interestingly, both ALK3 and
ALK6 receptors are highly expressed in developing kidneys
[37] and transgenic mice over-expressing a constitutively
active form of ALK3 in the UB lineage develop PKD [38]. In
our different HoxD deletions that induce PKD, down-
regulation of CDH1 and up-regulation of P-SMADs and C-
MYC expression levels were observed, similar to what was
scored in cystic tubules from ALK3 transgenic mice. We
consider this as an indication that the activation of the BMP/
GDF pathway, in our mutants, may be triggered by this
receptor. In this respect, it is noteworthy that the primary
function of ALK3 seems to be associated with apoptosis, at
least in developing limbs [39].
Model of Hoxd Gene Regulation during Kidney
Development
The distinct functions observed at the genetic level for
some ‘posterior’ and ‘anterior’ Hoxd genes in kidneys
correlate well with their speciﬁc expression in either the
MM or the UB, respectively ([7] and this work). The data
obtained using our collection of mutant strains suggest that
the distribution of Hoxd genes between these two renal
compartments is under the control of global enhancers,
resembling in this respect the regulation of the HoxD cluster
in the developing limbs and intestinal hernia [23]. In
developing kidneys, a putative mesenchyme enhancer may
control the expression of Hoxd12 to Hoxd9, whereas a ureteric
bud enhancer may control gene expression from Hoxd9 to
Hoxd1, Hoxd9 being thus the only gene responsive to both
enhancers (Figure 9C).
Because these expression speciﬁcities concern two differ-
ent cell types, it is likely that the regulation of Hoxd gene
expression in kidneys involves two distinct enhancer sequen-
ces. While the data shown here suggest that both of these
sequences unexpectedly reside at the telomeric end (or side)
of the cluster, their precise nature and location will have to
await a more extensive transgenic approach of the suspected
genomic region. As it stands, we cannot rule out the
possibility that a single global enhancer, controlling expres-
sion in both MM and UB, may be at work, involving various
cell-type or tissue-speciﬁc co-factors. Regardless of the
number of enhancers involved, the underlying mechanism(s)
must be complex to account for the quasi exclusion of the
two expression speciﬁcities, with the exception of Hoxd9. The
analysis of yet a few more genetic conﬁgurations will shed
some light on this issue, for example whether part of these
expression differences are due to the presence of silencer or
boundary elements, as reported in similar instances [40].
Materials and Methods
Mouse strains. Genomic rearrangements within the HoxD cluster,
including deletions (Del) or duplications (Dup), were all produced in
vivo through targeted meiotic recombination [41], except for the
Del(11–13), Del(4–13) and Del(1–13) lines, which were engineered by
loxP/Cre mediated site-speciﬁc recombination in ES cells [42–44].
These three lines were previously referred to as Del3, Del7 and Del9,
respectively. The Del(10–13), Del(i-9) and Dup(i-9) alleles were
previously described [45], whereas Del(12–13), Del(10–11), Del(4–
11), and Del(i-13) are novel alleles of the HoxD cluster. The Del(12–
13), Del(11–13), Del(i-13), Del(4–13) and Del(1–13) alleles also
contained the Hoxd11/lacZ fusion gene, allowing for histochemical
detection of b-galactosidase activity by X-gal staining [46]. Targeted
insertions of the Hoxd11/lacZ and Hoxd9/lacZ transgenes to the
posterior end of the HoxD cluster (TgH[d11/lac] and TgH[d9/lac]
strains, respectively) were reported previously [46,47]. The split of the
HoxD cluster, between Hoxd11 and Hoxd10 (Split(10–11), was
produced using the sequential targeted recombination-induced
genomic (STRING) approach [23].
Quantitative morphometric analysis. For histological analyses,
newborn kidneys were ﬁxed overnight at 48C with 4% PFA before
alcohol dehydration and parafﬁn embedding. The whole kidneys
were sectioned at 5 lm and stained with hematoxylin and eosin
according to standard protocols. Cortical and medullary volumes, as
well as glomerular density (number of glomeruli counted per kidney
volume) were determined in serial sections throughout entire kidneys
according to well established morphometric procedures [48], using
the ImageJ free software. For each mouse strain, four kidneys
obtained from separate newborn mice were investigated. The
independent Student’s t-test was used for all statistical analyses.
In situ hybridization. Embryonic or newborn kidneys were ﬁxed in
4% PFA and cryoprotected in 20% sucrose before embedding in
OCT compound. In situ hybridization was performed on 10 lm
cryosections by using digoxygenin-labelled riboprobes. Sections were
hybridized overnight at 658C with 2 lg/ml of riboprobe in the
following hybridization buffer: 50% formamide, 10% dextran sulfate,
1x Denhardt’s solution, 1 mg/ml yeast RNA, 200 mM NaCl, 1.1 mM
Tris-base, 8.9 mM Tris-HCl, 5 mM Na2HPO4, 5 mM NaH2PO4 and 5
mM EDTA. Two washes of 30 min at 658C were done in 50%
formamide, 1x SSC (0.15 M NaCl plus 0.015 M sodium citrate) and
0.1% Tween 20, followed by two washes at RT in TBS-T (137 mM
NaCl, 27 mM KCl, 25 mM Tris-base, 0.1% Tween 20, pH 7.5). Sections
were then incubated for one hour in a blocking buffer consisting of
20% goat serum and 2% blocking reagent (Roche) in TBS-T, and then
left overnight at 48C in an alkaline phosphatase-conjugated anti-
digoxigenin antibody (Roche) at a dilution of 1:2’000 in the blocking
buffer. Five washes of 20 minutes were done in TBS-T, and color
development was performed in NTMT (100 mM NaCl, 100 mM Tris,
50 mM MgCl2, 0.1% Tween 20, pH 9.5) containing both nitroblue
tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate (Roche). The
mouse antisense RNA probes for Hoxd genes were described
previously [45]. The Gdf5 probe was ampliﬁed by PCR, as reported
[49].
Immuno-ﬂuorescence and lectin staining. Immuno-ﬂuorescent
staining on kidney cryosections was carried out as follows: ﬁxation
for 10 minutes with 4% PFA; epitope retrieval for 20 minutes at 958C
in 0.01 M citrate buffer (pH 6.0); blockage for one hour with normal
goat serum; incubation overnight at 48C with the primary antibody:
anti-CDH1 (1:100, Cell Signaling), anti-ITGa3 (1:400, Chemicon),
anti-phospho-SMADs (1:50, Cell Signaling) or anti-C-MYC (1:100,
Santa Cruz Biotechnology); incubation with the Alexa Fluor-
conjugated secondary antibody (Alexa Fluor-488 or568, Invitrogen)
for one hour. For the detection of GDF5, immuno-ﬂuorescence was
performed using a monoclonal anti-GDF5 antibody (20 lg/ml, R&D
Systems) and the MOM immuno-detection kit as described by the
manufacturer (Vector Laboratories). To assess cell proliferation and
apoptosis in kidneys, a double staining was performed with a
combination of immuno-staining for anti-phospho-Histone-H3
(Ser10, Upstate) and TUNEL assay (TMR red, Roche) according to
the respective manufacturer’s instructions. Slides were subsequently
counterstained with DAPI (4’,6’-diamidino-2-phenylindole) for mi-
croscopic observation. Lectin staining was performed using ﬂuo-
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rescein isothiocyanate-coupled Dolichos biﬂorus agglutinin (DBA,
Vector Laboratories) as described previously [9].
Quantitative real-time RT-PCR. Single-stranded cDNA templates
were generated from total kidney RNAs using random hexamers and
Superscript II reagents (Invitrogen). For each mouse strain, at least
three kidneys from separate embryos or newborn mice were
investigated. Quantitative RT-PCR was carried out on an iCycler
thermal cycler (Bio-Rad) using SYBR green. PCR efﬁciencies and
dissociation curves of primer pairs were used to ensure speciﬁcity of
the amplicons. Tbp, Gapdh and Tubb4 genes were used as internal
controls for normalization. Primer sequences used for PCR ampliﬁ-
cation are listed in Table S1. New primer pairs were designed using
Primer Express 2.0 software (Applied biosystems).
Supporting Information
Figure S1. Del(1–13) Mutants Develop Polycystic Kidney Disease
Gross appearance of kidneys from control wild-type (WT) and
surviving Del(1–13) mutant mice at one month of age. The small size
of Del(1–13) kidneys was proportional to the overall reduced body
mass of the mutant animals.
Found at doi:10.1371/journal.pgen.0030232.sg001 (257 KB TIF).
Figure S2. Expression of Hoxa11/Hoxd11-Regulated Genes in Del(4–11)
and Del(4–13) Mutants
The expression pattern of various genes previously shown to be
modiﬁed in Hoxa11/Hoxd11 double mutant kidneys [17] was assessed
by qPCR from E13.5 to P0. Values represent the mean of three
independent experiments, after normalization to the WT at day
E13.5. Independent Student’s t test (HoxD deletions versus WT): *, P,
0.05.
Found at doi:10.1371/journal.pgen.0030232.sg002 (955 KB TIF).
Figure S3.Mis-Regulation of Hoxd13 in the Metanephric Mesenchyme
(A) Gross appearance of newborn kidneys from control WT and
TgH[d9/lac] heterozygous mice (top panels). The TgH[d9/lac] mouse
strain carried a Hoxd9/lacZ transgene relocated at the posterior end of
the HoxD cluster, upstream of the Evx2 gene [47]. Heterozygous mice
were used in this study, because homozygous mutants exhibit
complete kidney agenesis at early developmental stages. Kidney
sections from WT and TgH[d9/lac] strains were stained with H&E at
the newborn stage (middle panels), or were processed for the
detection of Hoxd13 by ISH at E13.5 (Hoxd13, bottom panels). The
TgH[d9/lac] strain displayed kidney hypoplasia, which coincided with
a gain of expression of Hoxd13 in the mesenchyme.
(B, C) The expression pattern of the indicated genes (from E13.5 to
P0) was compared in WT and TgH[d9/lac] heterozygous kidneys by
using qPCR. Student’s t test: *, P , 0.05; **, P , 0.01.
Found at doi:10.1371/journal.pgen.0030232.sg003 (1.8 MB TIF).
Figure S4. Expression of Renal Developmental Gene Markers in HoxD
Mutants
(A) Expression of various regulators of UB branching was assessed by
qPCR from E13.5 to P0. (B) qPCR measurements of the indicated
genes were performed in newborn kidneys. Independent Student’s t
test (HoxD deletions versus WT): *, P , 0.05; **, P , 0.01.
Found at doi:10.1371/journal.pgen.0030232.sg004 (1.0 MB TIF).
Figure S5. Posterior Hoxd Genes Are Not Affected in Del(i-9) Mutant
Kidneys
Kidney cryosections of WT and Del(i-9) homozygous strains were
processed for the detection of Hoxd10 by ISH at E13.5 (top panels),
and qPCR was used to compare the expression levels of Hoxd12,
Hoxd11 and Hoxd10 (bottom panels). Student’s t test: *, P , 0.05.
Found at doi:10.1371/journal.pgen.0030232.sg005 (971 KB TIF).
Table S1. Primers for Real-Time RT-PCR
Sequence of primers used in quantitative real-time RT-PCR. Primer
pairs described previously are indicated in the last column.
Found at doi:10.1371/journal.pgen.0030232.st001 (28 KB XLS).
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